Home » Topics » Regulatory » Patents

Patents
RSS

Novel porphycene compounds synthesized at Cytopharm

Dec. 2, 1996

New serotoninergic drugs from E. Merck

Nov. 29, 1996

Novel nonmacrolide antitumor agent discovered by Mitsubishi

Nov. 29, 1996

Takeda discloses natural ET receptor antagonist

Nov. 29, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

New bombesin analogues from Biomeasure

Nov. 29, 1996

Merck & Co. describes new compounds for dopamine-related disorders

Nov. 29, 1996

NEP inhibitors claimed by Santen

Nov. 28, 1996

Natural farnesyltransferase inhibitors from Kitasato Institute

Nov. 28, 1996

Natural antiplatelet agent discovered at Kitasato Institute

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...